Abstract:Nasopharyngeal carcinoma immunotherapy faces bottlenecks such as high tumor heterogeneity and poor model predictability. Traditional twodimensional culture and PDX models can hardly simulate the tumor microenvironment. In contrast, 3D bioprinting technology provides a novel platform for indepth exploration of tumor biology, drug screening, and personalized therapy by constructing tumorimmune coculture models. At present, research on 3Dbioprinted nasopharyngeal carcinoma spheroid models is still in the preliminary stage. This paper systematically reviews the core technologies, application value, and translational potential of 3D bioprinting in the construction of nasopharyngeal carcinoma spheroid models.